摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-azido-1-deoxy-β-D-glucopyranoside tetraacetate | 13992-25-1

中文名称
——
中文别名
——
英文名称
1-azido-1-deoxy-β-D-glucopyranoside tetraacetate
英文别名
2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl azide;tetra-O-acetyl-β-D-glucopyranosyl azide;(2R,3R,4S,5R,6R)-2-(acetoxymethyl)-6-azidotetrahydro-2H-pyran-3,4,5-triyl triacetate;1-azido-1-deoxy-2,3,4,6-tetra-O-acetyl-β-D-glucopyranose;1-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)azide;[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-azidooxan-2-yl]methyl acetate
1-azido-1-deoxy-β-D-glucopyranoside tetraacetate化学式
CAS
13992-25-1
化学式
C14H19N3O9
mdl
——
分子量
373.32
InChiKey
NHNYHKRWHCWHAJ-RKQHYHRCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    127-131 °C(lit.)
  • 沸点:
    502.57°C (rough estimate)
  • 密度:
    1.3271 (rough estimate)

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    26
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    129
  • 氢给体数:
    0
  • 氢受体数:
    11

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S22,S24/25
  • 危险类别码:
    R2
  • WGK Germany:
    3
  • 海关编码:
    29329990
  • 危险品运输编号:
    1325
  • 储存条件:
    2-8℃

SDS

SDS:4992ef59c4bb801eeaa97abb388d77d6
查看
Name: 2 3 4 6-Tetra-o-acetyl-betha-d-glucopyranosyl azide 98% Material Safety Data Sheet
Synonym:
CAS: 13992-25-1
Section 1 - Chemical Product MSDS Name:2 3 4 6-Tetra-o-acetyl-betha-d-glucopyranosyl azide 98% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
13992-25-1 2,3,4,6-TETRA-O-ACETYL-BETHA-D-GLUCOPY 98% unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.Light sensitive.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid if irritation develops or persists.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Keep under a nitrogen blanket.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 13992-25-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: beige
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 129 - 130 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C14H19N3O9
Molecular Weight: 373.32

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing materials.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 13992-25-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2,3,4,6-TETRA-O-ACETYL-BETHA-D-GLUCOPYRANOSYL AZIDE - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 13992-25-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 13992-25-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 13992-25-1 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

2,3,4,6-四-O-乙酰基-β-D-喃半乳糖叠氮化物是一种生物化学试剂,可用作生物材料或有机化合物,广泛应用于生命科学的相关研究中。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Helferich; Mitrowski, Chemische Berichte, 1952, vol. 85, p. 1,7
    摘要:
    DOI:
  • 作为产物:
    描述:
    beta-D-半乳糖五乙酸酯叠氮基三甲基硅烷四氯化锡 作用下, 以 二氯甲烷 为溶剂, 以88%的产率得到1-azido-1-deoxy-β-D-glucopyranoside tetraacetate
    参考文献:
    名称:
    Synthesis of acylated glycoconjugates as templates to investigate in vitro biopharmaceutical properties
    摘要:
    A series of novel glycopyranosyl azides were synthesised wherein the carbohydrate moiety was peracylated with four acetyl, propionyl, butanoyl, pentanoyl (valeryl) or 3-methylbutanoyl (isovaleryl) ester linked groups. A panel of glycoconjugates was synthesised from these glycopyranosyl azides using copper-catalysed azide-alkyne cycloaddition. The in vitro metabolic stability, plasma stability and plasma protein binding was then measured to establish the impact of the different acyl group when presented on a common scaffold. The acetyl, propionyl and butanoyl esters exhibited metabolism consistent with esterase processing, and various mono-, di- and tri-acylated hydrolysis products as well as the fully hydrolysed compound were detected. In contrast, the pentanoyl and 3-methylbutanoyl esters were stable. (c) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2012.11.056
点击查看最新优质反应信息

文献信息

  • Synthesis of new asparagine-based glycopeptides for future scanning tunneling microscopy investigations
    作者:Laura Sršan、Thomas Ziegler
    DOI:10.3762/bjoc.16.80
    日期:——
    disaccharides containing glycopeptides were prepared in solution. The applicability of two common peptide coupling reagents, using an orthogonal Fmoc/t-Bu strategy along with acetyl protecting groups for the carbohydrate moiety, was studied. Thus, the prepared libraries of glycopeptides were designed as model systems of cell surfaces for future investigations by combined preparative mass spectroscopy and
    为了研究寡糖和拟肽的生物学功能,在溶液中制备了新的含有糖肽的天冬酰胺基单糖和二糖。使用正交的Fmoc / t- Bu策略以及碳水化合物部分的乙酰基保护基,研究了两种常见的肽偶联剂的适用性。因此,将制备的糖肽文库设计为细胞表面的模型系统,以供将来通过在属表面上使用软着陆电喷雾束沉积(ES-IBD)的组合制备质谱和扫描隧道显微镜(STM)进行研究。
  • Stereospecific Synthesis of the α- and β-<scp>d</scp>-Glucopyranosyl Ureas
    作者:Yoshiyasu Ichikawa、Taihei Nishiyama、Minoru Isobe
    DOI:10.1021/jo0100751
    日期:2001.6.1
    A new, one-pot, two-stage procedure for the preparation of the alpha- and beta-D-glucopyranosyl ureas has been developed. Oxidation of glucopyranosyl isocyanides provides glucopyranosyl isocyanates, which can be trapped in situ with amines to afford good yields of glucopyranosyl ureas. Application of this method establishes the successful synthesis of the hitherto unknown N,N'-di-alpha,alpha- and alpha
    已经开发了一种新的,一锅,两阶段的制备α-和β-D-吡喃葡萄糖的方法。葡萄糖异氰酸酯的氧化提供了葡萄糖异氰酸酯,其可以用胺原位捕获以提供良好产率的葡萄糖。该方法的应用建立了迄今为止未知的N,N′-二-α,α-和α,β-D-吡喃葡萄糖的成功合成。
  • Copper-Catalyzed Huisgen and Oxidative Huisgen Coupling Reactions Controlled by Polysiloxane-Supported Amines (AFPs) for the Divergent Synthesis of Triazoles and Bistriazoles
    作者:Zhan-Jiang Zheng、Fei Ye、Long-Sheng Zheng、Ke-Fang Yang、Guo-Qiao Lai、Li-Wen Xu
    DOI:10.1002/chem.201202472
    日期:2012.10.29
    click reactions mediated by a polysiloxane‐supported secondary amine allow the preparation of novel heterocyclic compounds, that is, bistriazoles. Comparably, it is also surprising that the use of a diamine‐functional polysiloxane as ligand led to a classic Huisgen [3+2] cycloaddition in excellent yields. From the results of the present amine‐functional polysiloxanes‐controlled Huisgen reaction or oxidative
    在点击化学中成功地提出了一个有趣的例子,该例子采用(I)和胺官能大分子聚硅氧烷体系发散催化。在本手稿中,我们证明了仲胺官能聚硅氧烷叠氮化物炔烃介导的惠斯根反应中诱导氧化偶联的显着能力,从而获得了良好的收率和选择性。由聚硅氧烷负载的仲胺介导的点击反应可制备新型杂环化合物,即双三唑。相比之下,使用二胺官能化聚硅氧烷作为配体也导致了经典的Huisgen [3 + 2]环加成反应,且收率很高,这也令人惊讶。
  • First noscapine glycoconjugates inspired by click chemistry
    作者:Kunj B. Mishra、Ram C. Mishra、Vinod K. Tiwari
    DOI:10.1039/c5ra07321a
    日期:——
    A number of novel 7-O-noscapine glycoconjugates have been synthesized starting from noscapine, an alkaloid found in the opium plant, via two successive steps. The first step is a selective 7-O-demethylation of noscapine and the next is a subsequent propargylation which affords 7-O-propargyl noscapine (3) in good yield. The structure was confirmed by extensive spectroscopic data including single crystal
    已经通过两个连续的步骤,从鸦片植物中发现的一种生物碱-诺斯卡汀开始合成了许多新颖的7- O-诺斯卡汀糖缀合物。第一步是Noscapine的选择性7- O-去甲基化,第二步是随后的炔丙基化,以良好的收率得到7- O-炔丙基基Noscapine(3)。通过包括单晶X射线数据在内的大量光谱数据证实了该结构。研究了发达的Noscapine衍生物3与糖基叠氮化物6a–m的1,3-偶极环加成反应,得到了三唑连接的第二代Noscapine类似物,其糖缀合物形式(8a–m )以增强Noscapine的治疗功效。
  • Syntheses and structures of anomeric quaternary ammonium β-glucosides and comments on the anomeric C–N bond lengths
    作者:Lisa Iddon、Ryan A. Bragg、John R. Harding、Chandrakala Pidathala、John Bacsa、Anthony J. Kirby、Andrew V. Stachulski
    DOI:10.1016/j.tet.2009.05.086
    日期:2009.8
    We report convenient syntheses of anomeric quaternary ammonium β-glucosides in both protected and deprotected forms, together with X-ray structural investigations of two of the products. Both the quaternisation of a protected anomeric N,N-(dimethylamino)glucose, derived in two high-yielding steps from the anomeric azide, and the direct reaction of glucose or 6-O-trityl glucose with a secondary amine
    我们报告了保护和脱保护形式的端粒异构季β-葡萄糖苷的方便合成方法,以及两种产品的X射线结构研究。受保护的异头N,N-(二甲基基)葡萄糖的季化作用,是在两个高产步骤中从异头叠氮化物衍生而来的,并且葡萄糖或6- O-三苯甲基葡萄糖与仲胺直接反应,然后进行保护和季化是可行的路线。我们还讨论了在立体电子效应方面观察到的C–N键长和产物稳定性的重要性。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸